PPD, Inc., a $5.3 billion CRO headquartered in Wilmington, NC, will expand its presence in China, opening a global central lab services unit in Beijing in conjunction with Peking Union Lawke Biomedical Development Limited (PUL).  Presently, PPD has central labs in Brussels, Belgium, and Highland Heights, KY. The Beijing lab is closely coordinated with these two facilities and will offer the same services. The goal of the Beijing lab is to serve clients in China. More details... 

Stock Symbol: (NSDQ: PPDI)